Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party

In the context of a phase III trial comparing in advanced non-small cell lung cancer (NSCLC) sequential to conventional administration of cisplatin-based chemotherapy and paclitaxel, we evaluated the activity of paclitaxel as second-line chemotherapy and investigated any relation of its efficacy wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Berghmans, T, Lafitte, J J, Lecomte, J, Alexopoulos, C G, Van Cutsem, O, Giner, V, Efremidis, A, Berchier, M C, Collon, T, Meert, A P, Scherpereel, A, Ninane, V, Leclercq, N, Paesmans, M, Sculier, J P
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2007
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359915/
https://www.ncbi.nlm.nih.gov/pubmed/17473825
http://dx.doi.org/10.1038/sj.bjc.6603772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359915/
https://www.ncbi.nlm.nih.gov/pubmed/17473825
http://dx.doi.org/10.1038/sj.bjc.6603772

Ejemplares similares